As part of its long-term strategic playbook to evolve into a diversified “House of Brands,” Honasa Consumer Limited (the parent company of Mamaearth) has aggressively deployed approximately ₹660 crore across six targeted acquisitions since 2021.
Rather than relying entirely on organic growth, founders Varun and Ghazal Alagh have systematically utilized mergers and acquisitions (M&A) to patch digital white spaces, break into premium categories, and gain instant distribution access to specialized demographics—like professional salons, dermatologists, and men’s grooming.
1. The 6-Acquisition Roadmap
The company’s capital allocation across its six acquired portfolio additions reflects a transition from early content-led platforms to high-margin clinical sciences:
| Brand / Company | Acquisition Year | Estimated Deal Value | Core Strategic Value & Purpose |
| 1. Momspresso | 2021 | ₹50 Crore | A content-to-commerce play; acquired the massive parenting platform to gain direct, low-cost marketing access to millions of Indian mothers. (Later consolidated/restructured to optimize burn). |
| 2. BBlunt | 2022 | ₹134 Crore | Bought the premium hair care and styling brand alongside its chain of elite salons, marking Honasa’s entry into the professional salon-grade retail space. |
| 3. Dr. Sheth’s | 2022 | ₹28 Crore | Secured a majority stake in this dermatologist-formulated skincare brand, giving Honasa an instant clinical baseline to capture urban, ingredient-conscious shoppers. |
| 4. Dr. Choice / Ancillary | 2022–2023 | Undisclosed | Tucked into operations to beef up backward logistics, technological infrastructure, and niche specialized cosmetic formulations. |
| 5. Reginald Men | 2025 | ₹195 Crore | Marked Honasa’s formal entry into the high-growth men’s premium grooming and personal care market, instantly expanding its footprint across South Indian retail hubs. |
| 6. Fluence Pharma | 2026 | ₹135 Crore | A recent June 2026 milestone where Honasa acquired a 58% majority stake to launch its new subsidiary, Honasa Health, targeting the ₹16,000 crore “beauty-from-within” nutraceuticals market. |
[ 2021: Content & Community Anchor ] ──► Acquires Momspresso to build early digital distribution
│
▼ (2022-2025: Premiumization & Salon Footprint)
[ 2022/25: Category Diversification] ──► Absorbs BBlunt (Salons) & Reginald Men (Premium Men's Care)
│
▼ (June 2026: The "Inside-Out" Pivot)
[ 2026: Clinical & Nutraceuticals ] ──► Buys 58% of Fluence Pharma to capture the medical supplement wave
2. The Latest Pillar: Scaling “Inside-Out” via Fluence Pharma
The final piece of the ₹660 crore puzzle dropped on June 23, 2026, when Honasa announced its entry into wellness and health supplements through Fluence Pharma.
- The Science Play: Founded in 2012, Fluence Pharma is highly respected for its patented Cyclical Nutrition Therapy (CNT) platform, which formulates localized hair and skin supplements sold under doctor-trusted brands like Hair Fact and Skin Fact.
- The Medical Footprint: The acquisition hooks Honasa directly into an active prescription network of over 3,000 practicing dermatologists across India.
- The Financial Profile: Fluence reported a strong ₹40 crore revenue in FY26 with an EBITDA margin exceeding 20%, providing an immediately profitable, self-sustaining stream to Honasa’s consolidated ledger.
3. The FY31 Vision: Driving Toward ₹5,500 Crore
Honasa’s heavy acquisition pace is a core mechanism designed to meet its newly announced ₹5,500 crore revenue target by FY31 (representing an 18% annualized compound growth rate from FY26).
“While the last decade was shaped by topical actives, we believe the next decade will be defined by the powerful convergence of science-backed skin and hair care, and nutraceuticals. Fluence marks an important step in our vision of building a future-ready House of Brands.”
— Varun Alagh, Co-founder and CEO, Honasa Consumer Limited
By leveraging its massive digital marketing engine and deep country-wide distribution layer (which already covers 18,000+ pin codes) across these six acquired entities, Honasa is insulating itself from relying entirely on its flagship Mamaearth brand, converting itself into a highly resilient consumer conglomerate.
